UroGen Pharma Ltd. Ordinary Shares (URGN) Stock Price, Quote & AI Analysis
Live URGN stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for UroGen Pharma Ltd. Ordinary Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for UroGen Pharma Ltd. Ordinary Shares (URGN), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
UroGen Pharma Ltd. Ordinary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
UroGen Pharma Ltd. Ordinary Shares Overview
Company information
Company Overview
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
UroGen Pharma Ltd. Ordinary Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...